Japan's Warner Mycal First Theatrical Installation For D-BOX In Asia

LONGUEUIL, QC, Feb. 4 /PRNewswire-FirstCall/ - D-BOX Technologies Inc. (DBO.A on the TSX Venture Exchange), a leader in innovative motion technology for the entertainment industry, announced today the upcoming installation of a first movie theatre equipped with 13 D-BOX MFX seats with Warner Mycal Corporation, one of the largest operator of commercial theatres in Japan. This transaction marks the first sale of D-BOX motion systems for commercial theatre applications outside of North-America. D-BOX's international business model for commercial theatre applications is based on a combination of an upfront payment to D-BOX and licensing fees payable in accordance to the systems utilization.

"We are very pleased of teaming up with Warner Mycal in this first commercial theatre venture outside of North-America" declared Claude Mc Master, President and CEO of D-BOX Technologies. "The Japanese market is huge and their consumers are usually very savvy of new and exciting technologies. In addition, a presence in Japan will provide for a great technological showcase in a market that offers great long term potential. As we intend, over the next few quarters, to accelerate the deployment of our motion systems for commercial application in North-America, we see in this Asian venture an excellent opportunity to test new markets as we gradually become a true international standard".

"It is with great pleasure that we will proceed with the first commercial deployment of D-BOX motion systems for the Japanese Cinema Market as we intend to deploy 13 such systems at Warner Mycal Cinemas Ohdaka as part of a new state-of-the-art 10 screen, 1923 seats multiplex which will open next March 23 in Nagoya." stated Millard L. Ochs, President and Representative Director of Warner Mycal Corporation. "More specifically, we intend to equip theatre #10 with RealD digital 3D system and with D-BOX MFX seats allowing our customers to experiment a new and completely immersive cinema experience."

About Warner Mycal

Warner Mycal Corporation is a joint venture between Warner Bros. International Cinemas and Japan's leading retailer chain Aeon Group's Mycal. Ever since opening Japan's first cinema complex in 1993, the company has aggressively developed its cinemas across Japan, and grown into one of the biggest cinema complex operators with 60 theatres 493 screens. Besides D-BOX, the company is among the first to introduce advanced technologies and services such as RealD digital 3D cinema and the Sanyo air purification system which suppresses airborne viruses and bacteria in the theatre, and leads the cinema operation business in Japan.

About D-BOX

D-BOX Technologies designs and manufactures leading edge high-technology motion systems mainly suited to the needs of the entertainment industry. With its unique, patented technology, D-BOX Motion Code(TM) uses motion effects specifically programmed for each film, TV program or video game, which are sent to a motion generating system integrated within either a platform or a seat. The resulting motion is perfectly synchronised with all onscreen action, creating an unmatched realistic, immersive experience. To date, D-BOX Motion Code(TM) is available on more than 850 titles.

Accordingly, many prominent Hollywood studios have started embedding D-BOX Motion Code(TM) on selected high definition Blu-ray(TM) releases. By reaching agreements with the leaders of both the motion picture and gaming industries, D-BOX's award-winning motion technology is gradually proving itself as a new global standard in the entertainment world.

D-BOX is a publicly traded company listed on the TSX Venture exchange under the symbol DBO.A. For further information please see www.d-box.com. D-BOX(R) is a registered trademark and D-BOX Motion Code(TM) is a trademark of D-BOX Technologies Inc. Other names are for informational purposes only and may be trademarks of their respective owners.

Disclaimer in regards to Forward-Looking Statements

Certain statements included herein, including those that express management's expectations or estimates of our future performance, constitute "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Investors are cautioned not to put undue reliance on forward-looking statements.

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."

SOURCE D-BOX TECHNOLOGIES INC.